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ABSTRACT
Stellate ganglion blockage (SGB) is a method used for treating Raynaud’s phenomenon (RP).
This study primarily aimed to determine whether the perfusion index (PI) can be used an
alternative to Horner’s signs in evaluating the efficacy of SGB in patients diagnosed with RP.
In a total of 40 patients, aged 18–65 years and diagnosed with primary RP, SGB was applied
for 5 days on the same side with the 2-finger method, using 6 mL of 5% levobupivacaine at
the 7th cervical vertebra level. The PI values were recorded from the distal end of the 2nd
finger of the upper extremity on the side applied with the block at baseline and at 5, 15, 30,
60 and 120 min. The onset time of Horner findings was recorded. The PI values and visual
analogue scale (VAS) pain scores were recorded pre-treatment and after 2 weeks.When the PI
values of the 40 patients were examined, a 62.7% increase was observed from baseline to the
first session at 5 min (p < 0.05). When all sessions were evaluated, a statistically significant
increase was determined in the PI values measured at 5, 15, 30, 60 and 120 min compared
with the baseline PI values. There was a statistically significant decrease in the post-treatment
VAS pain scores and a statistically significant increase in the post-treatment PI values
(p < 0.05). By eliminating peripheral vasospasm with the application of SGB in patients with
RP, the distal artery blood flow and PI are increased. PI measurement is a more objective
method and therefore could be used as an alternative to Horner findings in evaluating the
success of SGB. PI is a non-invasive and simple measurement and also an earlier indicator in
evaluating the success of SGB than Horner’s signs.
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Raynaud’s phenomenon (RP) is characterised by a tem-
porary reduction in blood circulation associated with
vasospasm in the small arteries of the hands and feet
that is triggered by cold and emotional stress [1]. Patients
complain of pain together with pallor and/or cyanosis in
the distal two-thirds of the fingers. These symptoms may
be classified as a primary disorder (primary RP) or as
secondary to another disease such as a collagen tissue
disease (secondary RP) [2,3]. Primary Raynaud is a benign
disease that predominantly affects younger women and
is transient without serious sequelae. In contrast, second-
ary Raynaud is generally one of the symptoms of systemic
disease and is, in addition to findings of the basic disease,
associated with ischemic lesions. Primary Raynaud is
mainly diagnosed according to clinical presentation. In
secondary Raynaud, additional investigating techniques
including imaging studies and laboratory tests for the
detection of underlying disease are necessary [4].
Stellate ganglion blockage (SGB) is used for treating pain-
ful disorders of the upper extremity, head, neck and chest
as well as for Raynaud’s patients with a vasospastic
disorder [5]. Vasodilation occurs with the elimination of
the sympathetic effect following the block. The efficacy of
SGB is traditionally evaluated with the emergence of
Horner findings. Horner signs comprise unilateral miosis,
ptosis and facial anhydrosis [6]. The time to emergence of
these clinical findings may differ depending on the
patient or may be unclear [7]. The perfusion index (PI),
which is the ratio between pulsatile and non-pulsatile
signals, is calculated automatically and non-invasively as
a measurement of pulse oximetry [8]. Here, we investi-
gated whether the change in the PI could be used for
evaluating block efficacy as an alternative to the clinical
signs that emerge after SGB is applied. Treatment success
was also evaluated by comparing the PI values measured
2 weeks after treatment with the pre-treatment PI values.
2. Method
The study was approved by the Local Ethics
Committee, and informed consent was obtained
from all study participants. The study included a
total of 40 patients, aged 18–65 years and diagnosed
with primary RP, who were treated with SGB in the
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Algology Clinic of the Anaesthesiology and
Reanimation Department of Cumhuriyet University
Research and Application Hospital between June
2013 and December 2013. Patients were excluded if
they had additional systemic problems, were using
medication and/or had any concomitant disease that
could affect blood flow in the upper extremity, had an
infection in the area to be measured or if they
rejected the method or were not co-operative.
Patients were evaluated before the procedure. All
blocks were applied by the same person using the
same technique. For each patient, age, height, weight,
body mass index (BMI) and duration of disease were
recorded. Before the procedure, the 100-mm visual
analogue scale (VAS)-pain score was fully explained
to the patients, and the VAS pain scores between 0
and 10 (0 = no pain and 100 = worst possible pain)
were recorded to evaluate pain status before the
procedure. The pre-block measurements were taken
after the patient had rested for 15 min in a supine
position in a room at 24°C. Before the measurement, a
vascular route was opened in the patient with a 20G
intravenous catheter on the side where the block was
not to be applied. Fluid replacement was provided
with 0.9% NaCl solution at a volume of 10 mL/kg. The
patient was positioned supine, straight, with no cush-
ion support and arms in adduction. The patient’s head
was moved into slight extension and was held in
extension during the intervention. The oximetry sen-
sor (M-LNCS adult adhesive sensors connected to
Masimo SET® Radical™ pulse oximeters; Masimo
Corp, Irvine, CA, USA) was attached to the 2nd finger
of the upper extremity on the side where the proce-
dure was to be applied. The sensor was connected to
a Rad-87TM Pulse Co-Oximeter Monitor (Masimo).
Baseline PI, pulse and SpO2 values were recorded
from the monitor. The injection technique used for
the block was at the 7th cervical vertebra (C7) level
determined with the 2-finger method, wherein one
finger is placed on the jugular notch of the sternum,
and a second finger is placed laterally over the clavicle
to join the first finger. Next, two fingers of the other
hand are placed with one where this finger finishes,
and the other is placed vertically towards the neck.
The point where the fingers of the second hand finish
is defined as the point of injection. This point is
located over the transverse notch at C7 and along
the medial edge of the sternocleidomastoid muscle.
The area was aseptically cleaned and draped. After
the person who was to apply the block had taken
position on the side where the block was to be
applied, intradermal local anaesthesia (0.5 mL of 2%
prilocaine) was administered at the marked point. By
moving the sternocleidomastoid muscle inferiorally
and laterally with the first and second fingers of the
left hand, the carotid sheath was laterally pulled. After
palpating the carotid artery pulsation with the lateral
fingers, the skin was vertically entered at the marked
point with a 20G needle tip injector, containing 6 mL
of 5% levobupivacaine, held in the right hand, and the
needle was slowly advanced until the transverse
notch of the C7 vertebra was felt.
The aspiration test was applied by putting the
needle in contact with the transverse notch back up
to 0.5 cm, and 2 mL local anaesthetic was given. After
waiting for 15–20 s to determine whether an anaphy-
lactic or toxic reaction was observed, the remaining
local anaesthetic solution was administered (total
6 mL of 5% levobupivacaine). The time to emergence
of Horner findings and signs of facial redness and
dryness were recorded, and block success with
Horner findings was evaluated; non-Horner blocks
were considered unsuccessful. After the procedure,
the PI, SpO2 and pulse values were recorded using
the same method at 5, 15, 30, 60 and 120 min. The
block was applied once a day for 5 days on the same
side, and the measurements were repeated. After the
five sessions of block treatment were completed, all
patients attended a follow-up examination after
2 weeks, and, after the same physical conditions
were provided, the PI, SpO2 and pulse values as well
as the VAS scores were recorded.
2.1. Statistical analysis
The sample size of 28 patients per group was neces-
sary to detect a difference in PI, as previously
observed by Yamazaki et al. [7] who showed that
between groups, 5 min after SGB, the alpha error
level was set at 0.05 and 80% power to detect effect
size. The study data were analysed using SPSS
Statistics version 14.0 software. When the data met
parametric test assumptions, the Kolmogorov–
Smirnov test, Tukey test and the paired t test were
used, and when these data did not meet parametric
test assumptions, the Mann–Whitney U-test and the
Wilcoxon test were used. These data are shown as
mean ± standard deviation. A value of p < 0.05 was
accepted as statistically significant.
3. Results
The study included a total of 27 women and 13 men.
Demographic data of the patients are shown in
Table 1. SGB was applied a total of 200 times in five
sessions to 40 patients. In 188 (94%) of the proce-
dures, Horner findings and signs such as facial redness
and dryness were observed, and the block application
was recorded as successful.
When the procedures of the 1st session were evalu-
ated, a significant increase in the PI values was measured
at 5 min (2.36 ± 0.30) compared to baseline PI values
(1.45 ± 0.15) (p < 0.05). The increase in the PI values
measured from baseline to 5 min was 67%, and the
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increase from baseline to 15 min was 97.2%. When all
sessions were compared, a statistically significant differ-
ence was observed between the baseline PI values and PI
valuesmeasured at all timepoints (p < 0.05). The PI values
measured during all sessions are shown in Table 2.
In 188 applications evaluated as successful, the
mean time of Horner onset was 5.84 ± 1.55 min
(range, 3–10 min). In 107 applications, the time to
observation of Horner signs was longer than 5 min.
In patients where Horner signs had not yet devel-
oped, the PI values at 5 min after the block increased
61.7% compared to baseline values (p < 0.05). The PI
values were calculated as mean 1.06 ± 0.78 at baseline
and mean 1.28 ± 0.73 at 5 min in the 12 procedures
for which Horner signs did not occur.
No statistically significant difference was observed
in SpO2 and pulse values measured at different time
points in each session (p > 0.05). There was a statis-
tically significant difference of 56.6% in the PI values
measured at 2 weeks after treatment (2.24 ± 1.25)
compared to pre-treatment PI values (1.43 ± 0.98)
(p < 0.05). Moreover, there was a statistically signifi-
cant decrease in the VAS scores measured at 2 weeks
after treatment (3.00 ± 1.15) compared to pre-treat-
ment values (3.80 ± 1.57) (p < 0.05). The PI, SpO2 and
pulse values as well as the VAS scores of the patients
before and after treatment are shown in Table 3.
We observed hoarseness in three patients after SGB
in this study. Other complications such as haema-
toma, dyspnoea, hypotension and arrhythmia were
not observed.
4. Discussion
With the removal of the sympathetic effect following
SGB in patients with primary RP, peripheral blood flow
increases in the upper extremity [9], and PI values
begin to increase in proportion to the increase in
blood flow. This study demonstrated that PI, as a
non-invasive and simple measurement, showed suc-
cessful results in evaluating block success.
RP occurs with repeated, reversible constriction of
the small vessels in the distal ends of the hands and
feet [10]. Increased sympathetic activity is important
in the table that emerges. Treatment is effective in
controlling the increasing sympathetic activity [11].
SGB is a method used for treating Raynaud’s patients
as it increases blood flow in the upper extremity. In
evaluating whether the block is successful, clinical
signs such as Horner findings, hypohydrosis and facial
flushing are used, giving subjective results according
to the observer. These findings, which are based on
clinical observation, may be unclear in some patients.
In the evaluation of stellate sympathetic block, in
addition to Horner findings, many different methods
have been used based on the measurement of
increased temperature that occurs in areas affected
by the ganglion [12,13]. In this study, SGB was applied
five times to 40 patients. When all sessions of the
patients were separately evaluated, a statistically sig-
nificant increase was observed in the post-treatment
PI values measured at 5, 15, 30, 60 and 120 min
compared with the pre-treatment PI values (p < 0.05).
Table 1. Demographic data.
N = 40
Sex Male-Female 13–27 (32.5–67.5%)
Age (years) 19–55 (29.3)
Weight (kg) 49–86 (66.4)
Height (cm) 154–184 (166.6)
Disease duration (years) 1–12 (4.6)
BMI (kg/m2) 18.4–32.1 (23.9)
Data shown are total number, percentage, or range (mean).
BMI: Body mass index
Table 2. PI measurement values at each session.
1st session 2nd session 3rd session 4th session 5th session
Baseline 1.45 ± 0.15 1.56 ± 1.01 1.59 ± 1.42 1.70 ± 1.09 1.70 ± 1.06
5 min 2.36 ± 0.30 2.24 ± 1.03 2.76 ± 2.25 2.81 ± 1.65 3.13 ± 1.88
15 min 2.86 ± 0.27 2.83 ± 2.00 2.78 ± 1.70 3.15 ± 1.55 3.18 ± 1.64
30 min 2.70 ± 0.21 2.55 ± 1.33 2.50 ± 1.69 2.69 ± 1.42 3.11 ± 1.63
60 min 2.76 ± 0.24 2.24 ± 1.08 2.51 ± 1.33 2.35 ± 1.01 2.69 ± 1.69
120 min 2.41 ± 0.19 2.27 ± 1.17 2.71 ± 1.81 2.55 ± 1.48 2.62 ± 1.48
F = 10.98 F = 7.34 F = 6.12 F = 13.01 F = 10.47
p = 0.001* p = 0.001* p = 0.001* p = 0.001* p = 0.001*
p < 0.05 p < 0.05 p < 0.05 p < 0.05 p < 0.05
* Significant at P value of 0.05
Table 3. Pre- and post-treatment values.
Pre-treatment 2 weeks post-treatment Result
PI 1.43 ± 0.98* 2.24 ± 1.25 t = 3.74
p = 0.001
SpO2 97.75 ± 1.16 97.29 ± 1.32 t = 1.37
p = 0.171
VAS 3.80 ± 1.57* 3.00 ± 1.15 p = 0.001
Pulse 92.27 ± 10.54 90.20 ± 13.11 t = 0.76
p = 0.441
* Significant at P value of 0.05
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In our study, the injection technique used for the
block was at the C7 level determined with the 2-finger
method. Ultrasound-guided SGB is a safer procedure
compared to other techniques. It visualises vascular
structures (inferior thyroidal, cervical, vertebral and
carotid arteries) and soft tissue structures (thyroid,
oesophagus and nerve roots). Accordingly, the risk
of vascular and soft tissue injury may be minimal
[14]. Choi et al. [15] observed Horner signs in all 20
patients who had undergone ultrasound-guided SGB.
Nevertheless, complications may occur with ultra-
sound-guided blocks. Rastogui et al. [16] reported
cardiac arrest following ultrasound-guided SGB.
The PI, which is measured with pulse oximetry in a
specific measurement area, is the ratio between pulsa-
tile and non-pulsatile signals [8]. Increasing values indi-
cate an increase in peripheral circulation in the area
with the sensor. The efficacy of SGB can be evaluated
with increasing blood flow after the block. The results
of this study showed that PI can be successfully used in
evaluating SGB. In addition, PI monitorisation, which
can be measured with pulse oximetry, is a non-invasive
method that can be easily applied.
In recent studies, the importance of PI measure-
ment has been assessed in evaluating the efficacy of
both neuroaxial and peripheral nerve blocks. The
basic principle is vasodilation induced by sympathect-
omy. PI measurement is an alternative method pro-
viding rapid results rather than techniques such as
increased skin temperature and the pinprick test in
the evaluation of increased regional blood circulation
following nerve blocks. Kuş et al. [17] applied infra-
clavicular brachial plexus block under ultrasound gui-
dance to 46 patients undergoing elective upper
extremity surgery. After 10 min, the PI increased by
mean 120% compared to the baseline values. Based
on this result, they reported that PI could be used to
evaluate infraclavicular block success. Ginosar et al.
[18] placed a lumbar epidural catheter in 40 patients
and reported that the PI measurement gave earlier,
more sensitive and clearer information in the evalua-
tion of epidural-induced sympathectomy compared
to that of skin temperature and mean arterial pres-
sure. In this study, 188 applications were accepted as
successful based on the presence of signs such as
Horner signs. When the onset times of Horner find-
ings in the applications were examined, the earliest
was at 3 min, the latest was at 10 min and the mean
onset time was 5.84 ± 1.55 min. In 107 of the applica-
tions, the time to onset of Horner signs was >5 min.
An increase of 61.7% was observed in the PI value at
5 min compared to the baseline PI value in patients
who did not develop Horner signs within 5 min after
SGB. When evaluating the success of the block in light
of these results, it can be said that PI measurement
provides earlier data. It is not a tool to compare the PI
and Horner findings. Waiting for the time to emer-
gence of Horner findings is not sufficient to evaluate
SGB. Horner findings are visually evaluated by the
clinician. Some clinicians may say that Horner findings
are complete, whereas other clinicians may have not
fully observed it. The data obtained in this study are
consistent with the findings of both Kuş et al. and
Ginosar et al.
Oximeters capable of measuring PI have similar
cost ranges as other oximeters. Moreover, the time
difference between the two techniques can be mini-
mal or even unnoticed. The data obtained by PI mea-
surement are objective, but Horner findings are based
entirely on observational findings because the evalua-
tion of whether Horner findings such as myosis, ptosis
and facial anhidrosis are precisely formed may differ
according to the clinician.
In a retrospective study of 30 patients, Yamazaki
et al. observed that SGB treatment applied with
6 mL of 1% mepivacaine was accepted as effective
in 21 patients based on the presence of Horner
findings. In these 21 patients, an increase of
61.4% was observed in the PI values measured in
the ipsilateral ear lobe at 5 min compared to base-
line PI values, and an increase of 60.5% was
observed in the upper extremity. In two patients
with successful block and PI increase, the efficacy



















Figure 1. The change in PI values at different time points during the treatment sessions (y axis).
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laser Doppler flowmeter [7]. Similar results were
obtained in this study. When only the first session
of the patients was evaluated, an increase of 62.7%
was observed in the PI values at 5 min after SGB
compared to the baseline PI values (p < 0.05).
When all sessions were evaluated, there was a
statistically significant difference between the base-
line PI values and PI values measured at all time
points (p < 0.05) (Figure 1).
To evaluate the clinical status of Raynaud’s
patients and the effectiveness of the applied treat-
ment, symptomatic relief and pain levels are eval-
uated. Capillaroscopy, thermography, laser Doppler
and angiography methods can be used to evaluate
peripheral blood flow [19]. In this study, five ses-
sions of SGB treatment were applied over 5 days,
and PI values recorded before treatment were
compared with those recorded 2 weeks after treat-
ment. A statistically significant difference was
observed between the post-treatment PI value
(2.24 ± 1.25) and the pre-treatment PI value
(1.43 ± 0.98).
Hypoxia associated with recurring vasospasms in
RP causes pain. In this study, the VAS scores mea-
sured 2 weeks after treatment decreased compared
with those measured before treatment (p = 0.001)
(Table 3).
To the best of our knowledge, no other study
has reported the use of PI monitorisation in SGB
treatment in patients diagnosed with RP. In con-
clusion, the use of PI in regional anaesthesia can
increase the success of SGB as it is a rapid, non-
invasive and simple method providing measurable
data earlier compared to Horner signs and similar
clinical signs. However, further studies are required
to verify these results and to ensure that PI can be
used in treatment follow-up of patients with pri-
mary RP.
Disclosure statement
No potential conflict of interest was reported by the
authors.
ORCID




[1] Lambova SN, Müller-Ladner U. New lines in therapy of
Raynaud’s phenomenon. Rheumatol Int. (2009);29:355–
363.
[2] Landry GJ. Current medical and surgical management of
Raynaud’s syndrome. J Vasc Surg. 2013;57(6):1710–1716.
[3] Pope JE. The diagnosis and treatment of Raynaud’s
phenomenon. Drugs. 2007;67(4):517–525.
[4] Fardoun MM, Nassif J, Issa K, et al. Raynaud’s phenom-
enon: a brief review of the underlying mechanisms.
Front Pharmacol. 2016;7:438.
[5] Shiokawa Y, Morimoto M, Kamamoto H, et al. Usefulness
of perfusion index in evaluation of stellate ganglion
block. Acta Medica Kinki Univ. 2009;34(2):83–86.
[6] Vilallonga R, Fort JM, Mazarro A, et al. Postthyroidectomy
Horner’s syndrome Case Rep Med. 2012 (2012);316984.
[7] Yamazaki H, Nishiyama J, Suzuki T. Use of perfusion
index from pulse oximetry to determine efficacy of
stellate ganglion block. Local Reg Anesth. 2012;5:9–14.
[8] Lima A, Jansen TC, van Bommel J, et al. The prognostic
value of the subjective assessment of peripheral perfusion
in critically ill patients. Crit Care Med. 2009;37(3):934–938.
[9] Omote K, Kawamata M, Namiki A. Adverse effects of
stellate ganglion block on Raynaud’s phenomenon
associated with progressive systemic sclerosis. Anesth
Analg. 1993;77(5):1057–1060.
[10] Khouri C, Blaise S, Carpentier P, et al. Drug-induced
Raynaud’s phenomenon: beyond β-adrenoceptor block-
ers. Br J Clin Pharmacol. 2016;82(1):6–16.
[11] Hughes M, Herrick AL. Raynaud’s phenomenon. Best
Pract Res Clin Rheumatol. 2016;30(1):112–132.
[12] Malmqvist E-Å, Bengtsson M, Sörensen J. Efficacy of
stellate ganglion block: a clinical study with bupiva-
caine. Reg Anesth Pain Med. 1992;17(6):340–347.
[13] Murakawa K, Noma K, Ishida K, et al. Changes of tympanic
temperature by stellate ganglion block. Masui. 1995;44
(6):824–827.
[14] Narouze S. Ultrasound-guided stellate ganglion block:
safety and efficacy. Curr Pain Headache Rep. 2014;18
(6):424.
[15] Choi EM, Kim EM, Chung MH, et al. Effects of ultrasound-
guided stellate ganglion block on acute pain after arthro-
scopic shoulder surgery. Pain Physician. 2015;18(3):E379–
E388.
[16] Rastogi S, Tripathi S. Cardiac arrest following stellate
ganglion block performed under ultrasound guidance.
Anaesthesia. 2010;65(10):1042.
[17] Kus A, Gurkan Y, Gormus SK, et al. Usefulness of perfu-
sion index to detect the effect of brachial plexus block.
J Clin Monit Comput. 2013;27(3):325–328.
[18] Ginosar Y, Weiniger CF, Meroz Y, et al. Pulse oximeter
perfusion index as an early indicator of sympathect-
omy after epidural anesthesia. Acta Anaesthesiol
Scand. 2009;53(8):1018–1026.
[19] Dinsdale G, Herrick AL. Vascular diagnostics for
Raynaud’s phenomenon. J Vasc Diagn. 2014;2:127–139.
LIBYAN JOURNAL OF MEDICINE 5
